Indications for absorbable steroid-eluting sinus implants: Viewpoint via the Delphi method

Victoria S. Lee; Prayag Patel; Daniel O'Brien; George A. Scangas; Raewyn G. Campbell; Rakesh Chandra; Greg E. Davis; Joseph K. Han; Christopher H. Le; Jivianne Lee; Amber U. Luong; David M. Poetker; Hassan Ramadan; Michael Setzen; Kristine Smith; Sarah Wise; Jennifer Villwock; Elisabeth Ference

doi:10.1002/alr.23044

Indications for absorbable steroid-eluting sinus implants: Viewpoint via the Delphi method

Victoria S. Lee^*, Prayag Patel, Daniel O'Brien, George A. Scangas, Raewyn G. Campbell, Rakesh Chandra, Greg E. Davis, Joseph K. Han, Christopher H. Le, Jivianne Lee, Amber U. Luong, David M. Poetker, Hassan Ramadan, Michael Setzen, Kristine Smith, Sarah Wise, Jennifer Villwock, Elisabeth Ference

^*Corresponding author for this work

Macquarie Medical School

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

108 Downloads (Pure)

Abstract

Absorbable steroid-eluting sinus implants provide targeted corticosteroid release over a sustained period and are designed to prevent both undesirable adhesion formation and sinus ostia restenosis. Here, we highlight the key evidence of these implants to date and query a group of experts via a Delphi process on the indications and optimal timing for intraoperative or in-office placement of these implants. Six of a total of 12 statements reached consensus and were accepted. Overall, experts largely agree that intraoperative or in-office use of steroid-eluting stents could be considered for patients: (1) who are diabetic or intolerant of oral steroids, (2) undergoing extended frontal sinus surgery, and (3) with recurrent stenosis. Given the lack of expert consensus on other key statements, clinicians should carefully consider these treatment options on a case-by-case basis after shared decision-making.

Original language	English
Pages (from-to)	1225-1231
Number of pages	7
Journal	International Forum of Allergy and Rhinology
Volume	12
Issue number	10
DOIs	https://doi.org/10.1002/alr.23044
Publication status	Published - Oct 2022

Bibliographical note

Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

endoscopic sinus surgery
PROPEL
SINUVA
steroid-eluting implants

Access to Document

10.1002/alr.23044Licence: CC BY-NC-ND

Publisher version (open access)Final published version, 144 KBLicence: CC BY-NC-ND

Cite this

Lee, V. S., Patel, P., O'Brien, D., Scangas, G. A., Campbell, R. G., Chandra, R., Davis, G. E., Han, J. K., Le, C. H., Lee, J., Luong, A. U., Poetker, D. M., Ramadan, H., Setzen, M., Smith, K., Wise, S., Villwock, J., & Ference, E. (2022). Indications for absorbable steroid-eluting sinus implants: Viewpoint via the Delphi method. International Forum of Allergy and Rhinology, 12(10), 1225-1231. https://doi.org/10.1002/alr.23044

@article{a216e8d549194ad38d638933ab6816a0,

title = "Indications for absorbable steroid-eluting sinus implants: Viewpoint via the Delphi method",

abstract = "Absorbable steroid-eluting sinus implants provide targeted corticosteroid release over a sustained period and are designed to prevent both undesirable adhesion formation and sinus ostia restenosis. Here, we highlight the key evidence of these implants to date and query a group of experts via a Delphi process on the indications and optimal timing for intraoperative or in-office placement of these implants. Six of a total of 12 statements reached consensus and were accepted. Overall, experts largely agree that intraoperative or in-office use of steroid-eluting stents could be considered for patients: (1) who are diabetic or intolerant of oral steroids, (2) undergoing extended frontal sinus surgery, and (3) with recurrent stenosis. Given the lack of expert consensus on other key statements, clinicians should carefully consider these treatment options on a case-by-case basis after shared decision-making.",

keywords = "endoscopic sinus surgery, PROPEL, SINUVA, steroid-eluting implants",

author = "Lee, {Victoria S.} and Prayag Patel and Daniel O'Brien and Scangas, {George A.} and Campbell, {Raewyn G.} and Rakesh Chandra and Davis, {Greg E.} and Han, {Joseph K.} and Le, {Christopher H.} and Jivianne Lee and Luong, {Amber U.} and Poetker, {David M.} and Hassan Ramadan and Michael Setzen and Kristine Smith and Sarah Wise and Jennifer Villwock and Elisabeth Ference",

note = "Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2022",

month = oct,

doi = "10.1002/alr.23044",

language = "English",

volume = "12",

pages = "1225--1231",

journal = "International Forum of Allergy and Rhinology",

issn = "2042-6976",

publisher = "Wiley-Liss, Wiley",

number = "10",

}

Lee, VS, Patel, P, O'Brien, D, Scangas, GA, Campbell, RG, Chandra, R, Davis, GE, Han, JK, Le, CH, Lee, J, Luong, AU, Poetker, DM, Ramadan, H, Setzen, M, Smith, K, Wise, S, Villwock, J & Ference, E 2022, 'Indications for absorbable steroid-eluting sinus implants: Viewpoint via the Delphi method', International Forum of Allergy and Rhinology, vol. 12, no. 10, pp. 1225-1231. https://doi.org/10.1002/alr.23044

TY - JOUR

T1 - Indications for absorbable steroid-eluting sinus implants

T2 - Viewpoint via the Delphi method

AU - Lee, Victoria S.

AU - Patel, Prayag

AU - O'Brien, Daniel

AU - Scangas, George A.

AU - Campbell, Raewyn G.

AU - Chandra, Rakesh

AU - Davis, Greg E.

AU - Han, Joseph K.

AU - Le, Christopher H.

AU - Lee, Jivianne

AU - Luong, Amber U.

AU - Poetker, David M.

AU - Ramadan, Hassan

AU - Setzen, Michael

AU - Smith, Kristine

AU - Wise, Sarah

AU - Villwock, Jennifer

AU - Ference, Elisabeth

N1 - Copyright the Author(s) 2022. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2022/10

Y1 - 2022/10

N2 - Absorbable steroid-eluting sinus implants provide targeted corticosteroid release over a sustained period and are designed to prevent both undesirable adhesion formation and sinus ostia restenosis. Here, we highlight the key evidence of these implants to date and query a group of experts via a Delphi process on the indications and optimal timing for intraoperative or in-office placement of these implants. Six of a total of 12 statements reached consensus and were accepted. Overall, experts largely agree that intraoperative or in-office use of steroid-eluting stents could be considered for patients: (1) who are diabetic or intolerant of oral steroids, (2) undergoing extended frontal sinus surgery, and (3) with recurrent stenosis. Given the lack of expert consensus on other key statements, clinicians should carefully consider these treatment options on a case-by-case basis after shared decision-making.

AB - Absorbable steroid-eluting sinus implants provide targeted corticosteroid release over a sustained period and are designed to prevent both undesirable adhesion formation and sinus ostia restenosis. Here, we highlight the key evidence of these implants to date and query a group of experts via a Delphi process on the indications and optimal timing for intraoperative or in-office placement of these implants. Six of a total of 12 statements reached consensus and were accepted. Overall, experts largely agree that intraoperative or in-office use of steroid-eluting stents could be considered for patients: (1) who are diabetic or intolerant of oral steroids, (2) undergoing extended frontal sinus surgery, and (3) with recurrent stenosis. Given the lack of expert consensus on other key statements, clinicians should carefully consider these treatment options on a case-by-case basis after shared decision-making.

KW - endoscopic sinus surgery

KW - PROPEL

KW - SINUVA

KW - steroid-eluting implants

UR - http://www.scopus.com/inward/record.url?scp=85133369282&partnerID=8YFLogxK

U2 - 10.1002/alr.23044

DO - 10.1002/alr.23044

M3 - Article

C2 - 35730163

AN - SCOPUS:85133369282

SN - 2042-6976

VL - 12

SP - 1225

EP - 1231

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

IS - 10

ER -

Indications for absorbable steroid-eluting sinus implants: Viewpoint via the Delphi method

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this